Clinical Trials Logo
  1. Home
  2. Peripheral Nerve Injury
  3. NCT02352649

Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury

Peripheral Nerve Injury Clinical Trial

Official title:
1-2 Phase of Safety and Efficacy of Patient Intraneural Injections of VEGF165 Plasmid Gene Therapy on Regeneration After Total Severance or Disruption of the Entire Nerve Fiber

Clinical Trial Summary

The purpose of this study is to determine safety and efficacy of pl-vegf165 ("Neovasculgen") for regeneration of peripheral nerve. Pl-vegf165 ("Neovasculgen") is the permitted in Russian Federation angiogenic medication that induce growth of new vessels and included in a complex therapy for patients with peripheral arterial diseases in Russia. It has also been shown to enhance nerve regeneration and muscle reinnervation in animals but these properties have not previously been studied in patients. Moreover, currently there is no method in clinical use to speed the rate of recovery after nerve injury. The objective of this study is to explore the ability of pl-vegf165 to benefit the treatment of patients with peripheral nerve injury. The investigators hypothesize that treatment with intraneural injections with pl-vegf165 after peripheral nerve reconstruction will accelerate nerve regeneration, reduce the period of denervation and improve muscle reinnervation and recovery in patients with peripheral nerve injury.

Clinical Trial Description

All patients enrolled into the study will receive standard surgery procedures indicated in accordance with medical care standards for the certain disease. Patients after nerve injury classified as neurotmesis will receive surgical repair of injured nerves what will be added by intraneural injections of pl-vegf165. Safety and efficacy of gene therapy will be assessed by physical examination, comprehensive laboratory tests over next 18 month after surgical nerve reconstruction. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02352649
Study type Interventional
Source Human Stem Cell Institute, Russia
Contact Igor Plaksa
Phone +79112171859
Email i.plaksa2014@yandex.ru
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date April 2015
Completion date September 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02359825 - Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function Phase 1
Not yet recruiting NCT02865317 - Cortical Effects of Peripheral Nerve Injury At Birth N/A
Recruiting NCT01554722 - Needle Nerve Contact in Ultrasound Guided Femoral Block N/A
Recruiting NCT06071936 - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Phase 3
Recruiting NCT06071988 - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Phase 3
Recruiting NCT05541250 - Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI) Phase 1
Recruiting NCT06209632 - Mirror Therapy Combined With Contralaterally Controlled Functional Electrical Stimulation for Peripheral Nerve Injury N/A
Completed NCT01116362 - Comparing Primary With Secondary Repair of Based on Electrodiagnostic Assessment and Clinical Examination Phase 2
Withdrawn NCT04270019 - Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration Phase 1/Phase 2
Completed NCT01302275 - Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain Phase 4
Terminated NCT01088256 - Efficacy of Etoricoxib on Peripheral Hyperalgesia Phase 2
Completed NCT02228928 - Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain Phase 1/Phase 2
Withdrawn NCT00950391 - Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus Phase 1/Phase 2
Completed NCT00953277 - Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer Phase 4
Not yet recruiting NCT06003166 - 4-AP Peripheral Nerve Crossover Trial Phase 3
Not yet recruiting NCT02666456 - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain N/A
Terminated NCT02034461 - Micro-Electrodes Implanted in a Human Nerve N/A
Completed NCT01596491 - Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain N/A
Recruiting NCT03147313 - Extracorporal Shock Wave Treatment to Improve Nerve Regeneration N/A